NanoCross™ AB14W020120150Recalls & reported problems
Ev3, Inc · PTA AB14W020120150 NANOCROSS 014 V03 · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00821684059302), received between Dec 18, 2017 and Dec 18, 2017 — classified as 1 malfunction.
The most frequently reported specific device problem is “Shelf Life Exceeded” (1 report).
1 other recall cover devices cleared under the same FDA submission (K082854); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Shelf Life Exceeded1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 18, 2017Shelf Life Exceeded; Shelf Life Exceeded
IT WAS REPORTED THAT A NANOCROSS PTA BALLOON CATHETER DEVICE WAS USED TO TREAT A LESION IN THE ANTERIOR TIBIAL ARTERY. REPORTEDLY, THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED AND THE IFU WAS FOLLOWED BEFORE, DURING AND AFTER THE PROCEDURE. IT WAS REPORTED THAT THE DEVICE WAS PAST ITS EXPIRY DATE WHEN IT WAS USED. THE PHYSICIAN COMPLETED THE PROCEDURE SUCCESSFULLY AND NO PATIENT INJURY WAS REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7127278 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K082854. One submission often covers many models, so check the product and lot details in each record.
- Z-0789-2011 · Nov 12, 2010 · Terminatedev3 NanoCross 0.14 OTW PTA Dilatation Catheter, sterilized using ethylene oxide gas. REF #'s: AB14W040040150, AB14W030040150, AB14W020040150, AB14W025080150, AB14W020080150, AB14
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page